Drawing for ECLINICALOS

USPTO serial 86254675

ECLINICALOS

Reviewed by CopyMark Law Group

Reg. 4754361Status 710
Filing date
Status date
Registration date
Jun 16, 2015
Examiner
LEHKER, DAWN FELDMAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ECLINICALOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Valerie Calloway

Valerie Calloway International Business Machines Corp.1 North Castle DriveIntellectual Property- TrademarksArmonk, NY 10504

Goods and services

ClassDescriptionStatusFirst use
009Computer software for managing and sharing data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; downloadable software in the nature of a mobile application for use in managing data and information in the field of medical clinical trials and research; downloadable software in the nature of a mobile application for use in medical clinical trials, research monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchSECTION 8 - CANCELLED—
041Online journals, namely, blogs featuring news, information and commentary in the field of medical clinical trials and research; providing a website featuring blogs and non-downloadable publications in the nature of blogs in the field of medical clinical trials and research; providing educational training in the field of computer software for use in managing data and information in the field of medical clinical trials and researchSECTION 8 - CANCELLED—
042Software as a service (SAAS) solutions featuring software for use in managing data and information in the field of medical clinical trials and research; medical and scientific research, namely, conducting clinical trials; clinical trial protocol development in the nature of developing protocols for medical clinical trials and research; clinical trial planning and management in the nature of assisting with the development of medical clinical trials and research and the management of the data and information generated in medical clinical trials and research; clinical trial randomization and trial supply management in the nature of the management of data and information generated in medical clinical trials and research, for patient tracking and management, for patient randomization and enrollment, for pharmaceutical supply management and dosing, for logistics management, and for material inventory and supply management; clinical trial monitoring and events capture in the nature of the gathering and organizing the information and data generated in medical clinical trials and research; clinical data capture, management and reporting in the nature of the results of medical clinical trials and research; providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, providing online non-downloadable software for use in managing data and information in the field of medical clinical trials and research, namely, clinical trial protocol development, clinical trial planning and management, clinical trial user and learning management, clinical trial randomization and trial supply management, clinical trial monitoring and events capture, and clinical data capture, management and reportingSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 17, 2021C8..CANCELLED SEC. 8 (6-YR)—
Jun 16, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 17, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 17, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 24, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 16, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 25, 2015ALIEASSIGNED TO LIE—
Feb 5, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 4, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 29, 2014DOCKASSIGNED TO EXAMINER—
May 7, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 2, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
May 1, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance